Low-Flow CO2 Removal for Mild to Moderate ARDS With PRISMALUNG

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Acute Respiratory Distress Syndrome
Interventions
DEVICE

CO2 removal with PRISMALUNG in ARDS

Observational study of patients with mild to moderate Acute Respiratory Distress Syndrome (ARDS) submitted to Extracorporeal CO2 removal (ECCO2R) with the PRISMALUNG device to allow ultraprotective mechanical ventilation with tidal volume reduction (from 6 to 4 ml/kg, predicted body weight) and plateau pressure reduction from 28-30 to 23-25 cmH2O.

Trial Locations (5)

75013

Hopital Pitié Salpetriere, Reanimation Medicale, Paris

Unknown

CHU AMIENS, Département Anesthésie Réanimation, Amiens

CHU Besançon, Réanimation, Besançon

CHU CLERMONT FERRAND, Département Anesthésie Réanimation, Clermont-Ferrand

CHU MONTPELLIER, Département Anesthésie Réanimation, Montpellier

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire, Amiens

OTHER

collaborator

Centre Hospitalier Universitaire de Besancon

OTHER

collaborator

University Hospital, Clermont-Ferrand

OTHER

collaborator

University Hospital, Montpellier

OTHER

lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT02606240 - Low-Flow CO2 Removal for Mild to Moderate ARDS With PRISMALUNG | Biotech Hunter | Biotech Hunter